- Home
- MKLY vs SLS Comparison
MKLY vs SLS Comparison
Compare MKLY & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$4.00
Company Overview
Basic Information| Metric | MKLY | SLS |
|---|---|---|
| Founded | 2025 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 243.6M | 208.0M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | MKLY | SLS |
|---|---|---|
| Price | $10.01 | $4.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 77.1K | ★ 14.3M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.85 | $0.85 |
| 52 Week High | $10.05 | $5.18 |
Technical Indicators
Market Signals| Indicator | MKLY | SLS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 60.95 |
| Support Level | N/A | $3.23 |
| Resistance Level | N/A | $4.42 |
| Average True Range (ATR) | 0.00 | 0.63 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 0.00 | 54.73 |
Price Performance
Historical Comparison MKLY
SLS
About MKLY McKinley Acquisition Corporation Class A Ordinary Shares
McKinley Acquisition Corp is a blank check company.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.